7L1J image
Entry Detail
PDB ID:
7L1J
Keywords:
Title:
Mycobacterium tuberculosis dethiobiotin synthetase in complex with Tetrazole 1
Biological Source:
PDB Version:
Deposition Date:
2020-12-14
Release Date:
2021-10-27
Method Details:
Experimental Method:
Resolution:
1.60 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ATP-dependent dethiobiotin synthetase BioD
Chain IDs:A, B, C, D
Chain Length:233
Number of Molecules:4
Biological Source:Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Primary Citation
Inhibition of Mycobacterium tuberculosis Dethiobiotin Synthase ( Mt DTBS): Toward Next-Generation Antituberculosis Agents.
Acs Chem.Biol. 16 2339 2347 (2021)
PMID: 34533923 DOI: 10.1021/acschembio.1c00491

Abstact

Mycobacterium tuberculosis dethiobiotin synthase (MtDTBS) is a crucial enzyme involved in the biosynthesis of biotin in the causative agent of tuberculosis, M. tuberculosis. Here, we report a binder of MtDTBS, cyclopentylacetic acid 2 (KD = 3.4 ± 0.4 mM), identified via in silico screening. X-ray crystallography showed that 2 binds in the 7,8-diaminopelargonic acid (DAPA) pocket of MtDTBS. Appending an acidic group to the para-position of the aromatic ring of the scaffold revealed compounds 4c and 4d as more potent binders, with KD = 19 ± 5 and 17 ± 1 μM, respectively. Further optimization identified tetrazole 7a as a particularly potent binder (KD = 57 ± 5 nM) and inhibitor (Ki = 5 ± 1 μM) of MtDTBS. Our findings highlight the first reported inhibitors of MtDTBS and serve as a platform for the further development of potent inhibitors and novel therapeutics for the treatment of tuberculosis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures